HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The initial lesion in experimental allergic neuritis. A phase and electron microscopic study.

Abstract
Experimental allergic neuritis (EAN) was produced in rats by the intradermal injection of an emulsion of peripheral nerve in Freund's adjuvant. Early lesions in perfused sciatic nerves were studied by phase, light, and electron microscopy at intervals up to 15 days following immunization. Circulating lymphocytes attached focally to the inner surface of blood vessels, primarily venules, to initiate parenchymal lesion formation. Attached cells had the hand mirror configuration typical of the motile lymphocyte. They subsequently flattened against the endothelial surface and then traversed the vascular wall by sinking into and passing through the cytoplasm of endothelial cells. The transgressor and transgressed cell membranes were intact and both cells retained their integrity. Lymphocytes began to transform and divide intravascularly; these events accelerated extravascularly. Although the migrating cells became larger and more pleomorphic in the perivascular regions, their essential character was in keeping with an origin from circulating lymphocytes. In many lesions, there was fluid with protein, possibly produced by the transformed extravascular cells. The described cellular events precede tissue damage and are likely instrumental in the myelin destruction which follows
AuthorsK E Aström, H D Webster, B G Arnason
JournalThe Journal of experimental medicine (J Exp Med) Vol. 128 Issue 3 Pg. 469-95 (Sep 01 1968) ISSN: 0022-1007 [Print] United States
PMID4875326 (Publication Type: Journal Article)
Topics
  • Animals
  • Blood Vessels (cytology)
  • Female
  • Hypersensitivity, Delayed (pathology)
  • Injections, Intradermal
  • Lymphocytes
  • Male
  • Methods
  • Microscopy, Electron
  • Microscopy, Phase-Contrast
  • Neuritis (pathology)
  • Rabbits
  • Rats
  • Sciatic Nerve (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: